PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 161469

An animal model of fulminant hepatic failure in the rat.

A Watanabe·T Higashi·H Nagashima
View original source ↗Export metadata ↓

Abstract

A reproducible animal model of fulminant hepatic failure was developed by intraperitoneal administration of D-galactosamine hydrochloride to Sprague-Dawley rats. Biochemical and morphological hepatic injury and brain edema resembled human fulminant hepatic failure. This model would facilitate further studies of the pathogenesis of brain dysfunction and evaluation of treatment in fulminant hepatic failure.

Explore related subjects

Amino AcidsAnimalsBrainBrain ChemistryBrain EdemaChemical and Drug Induced Liver InjuryDisease Models, AnimalGalactosamineHepatic EncephalopathyLiverLiver DiseasesMaleRatsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Watanabe, T Higashi, H Nagashima. 1979. An animal model of fulminant hepatic failure in the rat.. https://pubmed.ncbi.nlm.nih.gov/161469/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Chimeric structural isomer fragments as cost-efficient internal standards for amino acid quantification by mass spectrometry.

Amino acid (AA) profiles from body fluids such as blood and urine are clinical indicators for diagnosing metabolic and hepatic diseases. Current quantitative methods, such as liquid chromatography-mass spectrometry (LC-MS) with isotopically labelled internal standards (ISs), are costly and technically demanding. This study proposes a cost-efficient alternative using structural isomers as ISs in a direct liquid infusion (DLI) tandem mass spectrometry (MS/MS) approach. The method leverages chimeric spectra and fragment intensity ratios to quantify AAs, demonstrating high linearity and precision even with a 3D ion trap mass analyser. This approach offers a viable strategy for AA quantification in preventive medicine, particularly for screening metabolic diseases such as phenylketonuria, diabetes, and liver dysfunction.

Amino Acids↗